HyperCube for Life Sciences
Find the root cause to your biggest business issues.
West Monroe Partners can help you apply HyperCube® for Life Sciences to maximize the power that resides in your data today and dramatically improve the way your organization makes decisions.

In the New World, post-blockbuster drug paradigm, life sciences organizations that survive are those that are quick, nimble and can rapidly react to information and take appropriate action. Processes designed with business rules from HyperCube® can speed up your reaction time. Consider:‹‹

  • Are you able to track and manage adverse drug reactions and product complaints and fix the root cause of problems?
  • ‹‹Do you understand your manufacturing processes? Are you struggling to validate, test and document all variables and parameters required to repeatedly make a quality product?
  • ‹‹Have you encountered unexplained problems with any particular products?
  • ‹‹Are you able to properly analyze data from clinical trials?
  • ‹‹Can you quickly decipher information for drugs in development to determine behaviors and patterns?

How well can you interpret data?

Statistical products and tools used to mine data may provide insight into as little as 20 percent of available data and are likely to “see” only tendencies or generalities. If you want to develop the precise insights necessary for success and profitable performance in today’s dynamic life sciences landscape, West Monroe Partners and HyperCube® can help.

Better, more complete answers
We can help you improve insight and decision making by applying HyperCube®, an innovative tool that provides more complete answers than any traditional statistical models to determine root causes and business rules that traditional solutions simply cannot produce. Use HyperCube® to answer your biggest operational issues and help you understand:‹‹

  • The root causes behind adverse drug reactions and product complaints
  • ‹‹Areas for improvement in your manufacturing processes & quality assurance procedures
  • ‹‹Key data implications from clinical trials and drugs in development

HyperCube® is a mathematical-based technology that derives business rules without the need for human-defined hypotheses. It utilizes state-of-the-art algorithms and unique computing capabilities to provide results with much greater precision than usual statistical methods. West Monroe applies this solution to help quickly derive answers to your most pressing issues, usually producing a complete set of business rules within a few weeks. We help you improve decision making West Monroe Partners combines deep life sciences experience with the complex event intelligence of HyperCube® to help you remove the limitations of traditional statistical analysis and maximize the power that resides in your data today. We work with you to leverage HyperCube®’s innovative “bottom-up” analysis—which eliminates the analytical biases and assumptions of averages or “best-fit” logic—to dramatically improve the way your organization makes decisions. We will work alongside your team to define the most impactful use cases and guide you in implementing the business rules discovered by HyperCube®.

Apply award-winning capabilities
More than 300 organizations across a wide range of industries have used HyperCube® to drive performance and competitive advantage. In fact, the MIT Sloan School recognized HyperCube® in its 2010 “Innovation Showcase” and
the Pasteur Institute named it the “best performing data analysis.”

How can HyperCube® help you address and fix your biggest issues? West Monroe Partners can show you how to harness its power to improve your understanding of and ability to manage: ‹‹

  • Adverse drug reactions
  • ‹‹Product complaints
  • ‹Manufacturing processes
  • ‹‹Product problems
  • ‹‹Clinical trial data analysis
  • ‹‹The drug development lifecycle

That’s business in the right direction.



West Monroe Insights
Non-Revenue Water (NRW): Challenges & Solutions
View More
Related Insights
Matt Barnes will present at Mergermarket’s Life Sciences and Healthcare M&A forum
Date : July 13, 2017 Time : 08:30 AM EST
Join West Monroe’s Matt Barnes at Mergermarket’s Life Sciences and Healthcare M&A forum as he discusses the science behind pharma mergers.
New York
How pharma companies can facilitate higher quality patient care at a lower cost.
Date : May 19, 2017
Pharmaceutical companies that have adopted a patient-centric approach have seen significant benefits in the form of greater patient adherence to medication, more consistent customer engagement, and overall improvements in the efficiency of their medical information and pharmacovigilance operations.
Natural Language Generation Goes to Work
Date : January 24, 2017

Natural Language Generation (NLG) is a form of artificial intelligence (AI) which takes an input of data and produces a narrative similar to how a human would interpret the data. NLG technology can be very transformative when used in business situations, especially in industries that are heavily dependent on generating text summaries based on straightforward conclusions drawn from structured data and that lack the capital to support a large workforce.